LTB4 antagonists (Sanwa)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLTB4 antagonists (Sanwa)
Drug Alias NameSK-814
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor antagonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorLeukotriene B4 receptor
Therapy Area/IndicationsUlcerInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanwa Kagaku Kenkyusho Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanwa Kagaku Kenkyusho Co Ltd
Active IndicationsN/A
Inactive IndicationsUlcerInflammation

Other Information

ATC CodeN/A
Related LinksN/A